Aquila of Delaware, Inc. Performance Audit

… istent and in compliance with Phase 1B of the signed grant agreements (known as the ‘Opioid Abatement and Remediation Grants’). 2. Determine whether grant expenditures had a demonstrable direct correlation with the related performance meas …

… stent and in compliance with Phase 1B of the signed grant agreements, (known as the ‘Opioid Abatement and Remediation Grants’). 2. That grant expenditures have a demonstrable direct correlation with the related performance measures, scope …

… d Impact Fund based on the recommendations of the Prescri ption Opioid Settlement Distribution Commission by awarding grants. In addition, in accordance with the signed grant agreement “Any entity that applies for and receives (“Recipient” …

… n of money from the Impact Fund and the Settlement Fund. The Commission, with the recommendation of the LGC, approved grants to 78 non-profit and governmental organizations in 2 phases, totaling $13,006,135 (Phase 1A: $3,656,039 & Phase 1B:$9 …

… ain an understanding of the legal and policy requirements governing the ‘Prescription Opioid Settlement Distribution’ grants. 2. We inquired whether there were any findings and recommendations in reports resulting from previous audits that …

… stent and in compliance with Phase 1B of the signed grant agreements, (known as the ‘Opioid Abatement and Remediation Grants’). Methodology - To assess the Organization’s compliance over opioid grant expenditures, we selected a random sampl …